Naltrindole, an opioid δ antagonist, blocks the enhancement of morphine-antinociception induced by a CCKB antagonist in the rat

Michael H. Ossipov, Carl J. Kovelowski, Todd W Vanderah, Frank Porreca

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

CCK has been shown to inhibit morphine antinociception, while antagonists of CCK receptors enhance morphine antinociceptive potency. These observations have led to the suggestion that CCK may function as an endogenous anti-opioid. Here, the involvement of the CCKB receptor in modulating the antinociceptive effects of morphine has been investigated by examination of the effects of a CCKB antagonist in the absence or presence of naltrindole, an opioid δ receptor antagonist. Intrathecal (i.th.) or subcutaneous (s.c.) L365,260 (a CCKB antagonist) did not produce any antinociceptive actions alone in either the rat tail-flick or hot-plate tests. L365,260 pretreatment enhanced the morphine antinociceptive response after either i.th. or s.c. administration. Naltrindole did not produce any antinociceptive effect alone and did not antagonize the antinociceptive actions of morphine after either i.th. or s.c. administration. However, naltrindole blocked the enhancement of morphine antinociception produced by L365,260 when evaluated by either route. These data suggest a tonic inhibition of enkephalin release by CCK via CCKB receptors. The subsequent enhancement of morphine antinociceptive potency may reflect the well-known modulation of morphine by enkephalins acting at opioid δ receptors.

Original languageEnglish (US)
Pages (from-to)9-12
Number of pages4
JournalNeuroscience Letters
Volume181
Issue number1-2
DOIs
StatePublished - Nov 7 1994

Fingerprint

naltrindole
Narcotic Antagonists
Morphine
Enkephalins
Cholecystokinin Receptors
Opioid Receptors

Keywords

  • Antinociception
  • Cholecystokinin
  • Naltrindole
  • Spinal cord
  • δ Opioid receptor

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Naltrindole, an opioid δ antagonist, blocks the enhancement of morphine-antinociception induced by a CCKB antagonist in the rat. / Ossipov, Michael H.; Kovelowski, Carl J.; Vanderah, Todd W; Porreca, Frank.

In: Neuroscience Letters, Vol. 181, No. 1-2, 07.11.1994, p. 9-12.

Research output: Contribution to journalArticle

@article{2e1d86f5ae14435995d6c9f8a0508ae9,
title = "Naltrindole, an opioid δ antagonist, blocks the enhancement of morphine-antinociception induced by a CCKB antagonist in the rat",
abstract = "CCK has been shown to inhibit morphine antinociception, while antagonists of CCK receptors enhance morphine antinociceptive potency. These observations have led to the suggestion that CCK may function as an endogenous anti-opioid. Here, the involvement of the CCKB receptor in modulating the antinociceptive effects of morphine has been investigated by examination of the effects of a CCKB antagonist in the absence or presence of naltrindole, an opioid δ receptor antagonist. Intrathecal (i.th.) or subcutaneous (s.c.) L365,260 (a CCKB antagonist) did not produce any antinociceptive actions alone in either the rat tail-flick or hot-plate tests. L365,260 pretreatment enhanced the morphine antinociceptive response after either i.th. or s.c. administration. Naltrindole did not produce any antinociceptive effect alone and did not antagonize the antinociceptive actions of morphine after either i.th. or s.c. administration. However, naltrindole blocked the enhancement of morphine antinociception produced by L365,260 when evaluated by either route. These data suggest a tonic inhibition of enkephalin release by CCK via CCKB receptors. The subsequent enhancement of morphine antinociceptive potency may reflect the well-known modulation of morphine by enkephalins acting at opioid δ receptors.",
keywords = "Antinociception, Cholecystokinin, Naltrindole, Spinal cord, δ Opioid receptor",
author = "Ossipov, {Michael H.} and Kovelowski, {Carl J.} and Vanderah, {Todd W} and Frank Porreca",
year = "1994",
month = "11",
day = "7",
doi = "10.1016/0304-3940(94)90548-7",
language = "English (US)",
volume = "181",
pages = "9--12",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Naltrindole, an opioid δ antagonist, blocks the enhancement of morphine-antinociception induced by a CCKB antagonist in the rat

AU - Ossipov, Michael H.

AU - Kovelowski, Carl J.

AU - Vanderah, Todd W

AU - Porreca, Frank

PY - 1994/11/7

Y1 - 1994/11/7

N2 - CCK has been shown to inhibit morphine antinociception, while antagonists of CCK receptors enhance morphine antinociceptive potency. These observations have led to the suggestion that CCK may function as an endogenous anti-opioid. Here, the involvement of the CCKB receptor in modulating the antinociceptive effects of morphine has been investigated by examination of the effects of a CCKB antagonist in the absence or presence of naltrindole, an opioid δ receptor antagonist. Intrathecal (i.th.) or subcutaneous (s.c.) L365,260 (a CCKB antagonist) did not produce any antinociceptive actions alone in either the rat tail-flick or hot-plate tests. L365,260 pretreatment enhanced the morphine antinociceptive response after either i.th. or s.c. administration. Naltrindole did not produce any antinociceptive effect alone and did not antagonize the antinociceptive actions of morphine after either i.th. or s.c. administration. However, naltrindole blocked the enhancement of morphine antinociception produced by L365,260 when evaluated by either route. These data suggest a tonic inhibition of enkephalin release by CCK via CCKB receptors. The subsequent enhancement of morphine antinociceptive potency may reflect the well-known modulation of morphine by enkephalins acting at opioid δ receptors.

AB - CCK has been shown to inhibit morphine antinociception, while antagonists of CCK receptors enhance morphine antinociceptive potency. These observations have led to the suggestion that CCK may function as an endogenous anti-opioid. Here, the involvement of the CCKB receptor in modulating the antinociceptive effects of morphine has been investigated by examination of the effects of a CCKB antagonist in the absence or presence of naltrindole, an opioid δ receptor antagonist. Intrathecal (i.th.) or subcutaneous (s.c.) L365,260 (a CCKB antagonist) did not produce any antinociceptive actions alone in either the rat tail-flick or hot-plate tests. L365,260 pretreatment enhanced the morphine antinociceptive response after either i.th. or s.c. administration. Naltrindole did not produce any antinociceptive effect alone and did not antagonize the antinociceptive actions of morphine after either i.th. or s.c. administration. However, naltrindole blocked the enhancement of morphine antinociception produced by L365,260 when evaluated by either route. These data suggest a tonic inhibition of enkephalin release by CCK via CCKB receptors. The subsequent enhancement of morphine antinociceptive potency may reflect the well-known modulation of morphine by enkephalins acting at opioid δ receptors.

KW - Antinociception

KW - Cholecystokinin

KW - Naltrindole

KW - Spinal cord

KW - δ Opioid receptor

UR - http://www.scopus.com/inward/record.url?scp=0027944479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027944479&partnerID=8YFLogxK

U2 - 10.1016/0304-3940(94)90548-7

DO - 10.1016/0304-3940(94)90548-7

M3 - Article

C2 - 7898778

AN - SCOPUS:0027944479

VL - 181

SP - 9

EP - 12

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1-2

ER -